vs
Cytek Biosciences, Inc.（CTKB）与Northfield Bancorp, Inc.（NFBK）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Northfield Bancorp, Inc.的1.5倍（$62.1M vs $41.3M），Cytek Biosciences, Inc.净利率更高（-70.9% vs -1545.5%，领先1474.6%），Northfield Bancorp, Inc.同比增速更快（12.7% vs 8.1%），Northfield Bancorp, Inc.自由现金流更多（$52.5M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 15.0%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
诺斯菲尔德银行控股公司是总部位于美国的区域性银行机构，主要服务美国东北部市场，面向个人消费者、中小企业及本地社区客户提供储蓄存款、住房贷款、商业信贷、财富管理等多元银行服务。
CTKB vs NFBK — 直观对比
营收规模更大
CTKB
是对方的1.5倍
$41.3M
营收增速更快
NFBK
高出4.6%
8.1%
净利率更高
CTKB
高出1474.6%
-1545.5%
自由现金流更多
NFBK
多$54.3M
$-1.8M
两年增速更快
CTKB
近两年复合增速
15.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $41.3M |
| 净利润 | $-44.1M | $-27.4M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | -1263.3% |
| 净利率 | -70.9% | -1545.5% |
| 营收同比 | 8.1% | 12.7% |
| 净利润同比 | -557.1% | -343.6% |
| 每股收益（稀释后） | — | $-0.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBNFBK
| Q4 25 | $62.1M | $41.3M | ||
| Q3 25 | $52.3M | $39.2M | ||
| Q2 25 | $45.6M | $38.9M | ||
| Q1 25 | $41.5M | $34.8M | ||
| Q4 24 | $57.5M | $36.7M | ||
| Q3 24 | $51.5M | $31.8M | ||
| Q2 24 | $46.6M | $31.5M | ||
| Q1 24 | $44.9M | $31.3M |
净利润CTKBNFBK
| Q4 25 | $-44.1M | $-27.4M | ||
| Q3 25 | $-5.5M | $10.8M | ||
| Q2 25 | $-5.6M | $9.6M | ||
| Q1 25 | $-11.4M | $7.9M | ||
| Q4 24 | $9.6M | $11.3M | ||
| Q3 24 | $941.0K | $6.5M | ||
| Q2 24 | $-10.4M | $6.0M | ||
| Q1 24 | $-6.2M | $6.2M |
毛利率CTKBNFBK
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBNFBK
| Q4 25 | -9.0% | -1263.3% | ||
| Q3 25 | -17.6% | 37.7% | ||
| Q2 25 | -23.3% | 35.6% | ||
| Q1 25 | -36.1% | 31.0% | ||
| Q4 24 | 5.2% | 38.0% | ||
| Q3 24 | -8.2% | 27.9% | ||
| Q2 24 | -18.3% | 29.1% | ||
| Q1 24 | -23.9% | 27.2% |
净利率CTKBNFBK
| Q4 25 | -70.9% | -1545.5% | ||
| Q3 25 | -10.5% | 27.4% | ||
| Q2 25 | -12.2% | 24.6% | ||
| Q1 25 | -27.5% | 22.6% | ||
| Q4 24 | 16.8% | 30.7% | ||
| Q3 24 | 1.8% | 20.5% | ||
| Q2 24 | -22.4% | 18.9% | ||
| Q1 24 | -13.8% | 19.9% |
每股收益（稀释后）CTKBNFBK
| Q4 25 | — | $-0.68 | ||
| Q3 25 | — | $0.27 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | — | $0.19 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $164.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $690.1M |
| 总资产 | $461.5M | $5.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBNFBK
| Q4 25 | $90.9M | $164.0M | ||
| Q3 25 | $93.3M | $131.7M | ||
| Q2 25 | $75.5M | $97.6M | ||
| Q1 25 | $95.3M | $101.7M | ||
| Q4 24 | $98.7M | $167.7M | ||
| Q3 24 | $162.3M | $232.9M | ||
| Q2 24 | $177.9M | $153.5M | ||
| Q1 24 | $168.8M | $238.8M |
总债务CTKBNFBK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $666.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CTKBNFBK
| Q4 25 | $341.7M | $690.1M | ||
| Q3 25 | $378.6M | $719.6M | ||
| Q2 25 | $377.6M | $710.3M | ||
| Q1 25 | $379.6M | $711.1M | ||
| Q4 24 | $395.7M | $704.7M | ||
| Q3 24 | $385.5M | $699.6M | ||
| Q2 24 | $389.1M | $693.0M | ||
| Q1 24 | $392.6M | $698.4M |
总资产CTKBNFBK
| Q4 25 | $461.5M | $5.8B | ||
| Q3 25 | $494.9M | $5.7B | ||
| Q2 25 | $493.3M | $5.7B | ||
| Q1 25 | $482.6M | $5.7B | ||
| Q4 24 | $499.5M | $5.7B | ||
| Q3 24 | $491.2M | $5.7B | ||
| Q2 24 | $483.7M | $5.7B | ||
| Q1 24 | $492.1M | $5.9B |
负债/权益比CTKBNFBK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $53.7M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $52.5M |
| 自由现金流率自由现金流/营收 | -2.9% | 127.1% |
| 资本支出强度资本支出/营收 | 1.6% | 2.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $89.2M |
8季度趋势，按日历期对齐
经营现金流CTKBNFBK
| Q4 25 | $-771.0K | $53.7M | ||
| Q3 25 | $-3.9M | $13.9M | ||
| Q2 25 | $108.0K | $14.1M | ||
| Q1 25 | $-125.0K | $9.4M | ||
| Q4 24 | $2.0M | $31.1M | ||
| Q3 24 | $13.2M | $14.0M | ||
| Q2 24 | $6.2M | $6.9M | ||
| Q1 24 | $4.0M | $4.2M |
自由现金流CTKBNFBK
| Q4 25 | $-1.8M | $52.5M | ||
| Q3 25 | $-4.6M | $13.6M | ||
| Q2 25 | $-1.5M | $13.9M | ||
| Q1 25 | $-974.0K | $9.2M | ||
| Q4 24 | $1.1M | $30.0M | ||
| Q3 24 | $12.2M | $13.7M | ||
| Q2 24 | $5.2M | $6.7M | ||
| Q1 24 | $3.4M | $3.8M |
自由现金流率CTKBNFBK
| Q4 25 | -2.9% | 127.1% | ||
| Q3 25 | -8.7% | 34.6% | ||
| Q2 25 | -3.2% | 35.7% | ||
| Q1 25 | -2.3% | 26.3% | ||
| Q4 24 | 1.9% | 81.6% | ||
| Q3 24 | 23.7% | 43.2% | ||
| Q2 24 | 11.0% | 21.1% | ||
| Q1 24 | 7.6% | 12.1% |
资本支出强度CTKBNFBK
| Q4 25 | 1.6% | 2.8% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.7% | ||
| Q4 24 | 1.6% | 3.1% | ||
| Q3 24 | 2.0% | 0.7% | ||
| Q2 24 | 2.3% | 0.8% | ||
| Q1 24 | 1.3% | 1.4% |
现金转化率CTKBNFBK
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | 0.21× | 2.76× | ||
| Q3 24 | 14.05× | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NFBK
暂无分部数据
